Poddubnaia I V
Ter Arkh. 1985;57(2):103-6.
Based on the use in 119 patients, the COP scheme can be regarded as an effective method of drug therapy of lymphosarcoma of the gastrointestinal tract: the total efficacy amounts to 65.4% and is practically identical in primary (61.8%) and metastatic (70%) involvement of the alimentary tube into the pathological process. However, the attainment of complete remissions was stated in an insignificant number of patients (16%). The five-year survival is equal to 60.2%.
基于对119例患者的应用情况，COP方案可被视为治疗胃肠道淋巴肉瘤的一种有效药物治疗方法：总有效率达65.4%，在消化道原发性（61.8%）和转移性（70%）受累于病理过程的情况下实际相同。然而，仅有少数患者（16%）实现了完全缓解。五年生存率为60.2%。
